Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases

M. Kolbeková (Praha, Czech Republic)

Source: International Congress 2017 – Lung fibrosis: basic science
Session: Lung fibrosis: basic science
Session type: Thematic Poster
Number: 905
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kolbeková (Praha, Czech Republic). Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases. 905

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010

Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015

The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid
Source: International Congress 2015 – IPF pathogenesis
Year: 2015

Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003



Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021
Year: 2022



Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

Bronchoalveolar lavage fluid Interferon-gamma levels and natural killer activity in cryptogenic fibrosing alveolitis
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003

Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011

Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016